Northeast ALS Consortium Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03127514
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

North East Amyotrophic Lateral Sclerosis Consortium